Two non-familial cases of Galloway-Mowat syndrome carrying the homozygous mutations of WDR73 and TP53RK

IF 0.3 Q3 MEDICINE, GENERAL & INTERNAL
Ehsan Valavi, Elham Fatahinezhad
{"title":"Two non-familial cases of Galloway-Mowat syndrome carrying the homozygous mutations of WDR73 and TP53RK","authors":"Ehsan Valavi, Elham Fatahinezhad","doi":"10.15448/1980-6108.2023.1.44296","DOIUrl":null,"url":null,"abstract":"Galloway–Mowat syndrome (GAMOS) is a rare hereditary disease manifested as a combination of nephrotic syndrome and central nervous system impairment. To date, many GAMOS cases attributed to various gene mutations have been reported such as WHAMM, NUP107, WDR73, OSGEP, and TP53RK. We detected two novel homozygous mutations of WDR73 ‘’NM_032856:c.G287A:p.R96K‘’ and TP53RK ‘’NM_033550:c.A193O:p.K65Q‘’ in two female kids of the consanguineous parents from different families using whole exome sequencing. Both patients almost manifested similar neurodegenerative phenotypes, including developmental delay, microcephaly, hypotonia, and brain atrophy on magnetic resonance imaging during infancy. WDR73-positive GAMOS case manifested a late-onset minimal nephrotic syndrome at the age 4 years while TP53RK-positive case presented nephrotic syndrome at the age 1 which progressed to steroid-resistant nephrotic syndrome due to lack of remission after 4-6 weeks of initial treatment with prednisone. Despite the brain abnormalities and the onset time difference of renal abnormalities, both patients are still alive. Given the heterogeneity of the renal phenotype among GAMOS types, accurate recognition of expanding spectrum of phenotype findings and regular renal function screening are necessary for an early diagnosis and timely treatment.","PeriodicalId":44024,"journal":{"name":"Scientia Medica","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scientia Medica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15448/1980-6108.2023.1.44296","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Galloway–Mowat syndrome (GAMOS) is a rare hereditary disease manifested as a combination of nephrotic syndrome and central nervous system impairment. To date, many GAMOS cases attributed to various gene mutations have been reported such as WHAMM, NUP107, WDR73, OSGEP, and TP53RK. We detected two novel homozygous mutations of WDR73 ‘’NM_032856:c.G287A:p.R96K‘’ and TP53RK ‘’NM_033550:c.A193O:p.K65Q‘’ in two female kids of the consanguineous parents from different families using whole exome sequencing. Both patients almost manifested similar neurodegenerative phenotypes, including developmental delay, microcephaly, hypotonia, and brain atrophy on magnetic resonance imaging during infancy. WDR73-positive GAMOS case manifested a late-onset minimal nephrotic syndrome at the age 4 years while TP53RK-positive case presented nephrotic syndrome at the age 1 which progressed to steroid-resistant nephrotic syndrome due to lack of remission after 4-6 weeks of initial treatment with prednisone. Despite the brain abnormalities and the onset time difference of renal abnormalities, both patients are still alive. Given the heterogeneity of the renal phenotype among GAMOS types, accurate recognition of expanding spectrum of phenotype findings and regular renal function screening are necessary for an early diagnosis and timely treatment.
两例携带WDR73和TP53RK纯合突变的非家族性加洛韦-莫瓦特综合征病例
伽洛韦-莫瓦特综合征(GAMOS)是一种罕见的遗传性疾病,表现为肾病综合征和中枢神经系统损害的结合。迄今为止,许多GAMOS病例归因于各种基因突变,如WHAMM、NUP107、WDR73、OSGEP和TP53RK。我们检测到两个新的WDR73“NM_032856:c.G287A:p。R96K "和TP53RK " NM_033550: c.a 1930o:p。利用全外显子组测序,对来自不同家庭的近亲父母的两个女性孩子的K65Q基因进行了分析。两例患者在婴儿期磁共振成像上几乎表现出相似的神经退行性表型,包括发育迟缓、小头畸形、张力低下和脑萎缩。wdr73阳性GAMOS病例在4岁时表现为晚发性轻度肾病综合征,而tp53rk阳性病例在1岁时表现为肾病综合征,由于泼尼松初始治疗4-6周后缺乏缓解,进展为类固醇抵抗性肾病综合征。尽管存在脑异常和肾异常的发病时间差异,但两例患者仍然存活。鉴于GAMOS类型间肾脏表型的异质性,准确识别不断扩大的表型发现谱并定期进行肾功能筛查对于早期诊断和及时治疗是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Scientia Medica
Scientia Medica MEDICINE, GENERAL & INTERNAL-
CiteScore
0.70
自引率
20.00%
发文量
14
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信